Genomically guided targeted therapy can improve progression-free survival for patients with metastatic breast cancer whose tumors bear mutations known to be sensitive to targeted therapies.

©2022 American Association for Cancer Research.
2022
American Association for Cancer Research.
You do not currently have access to this content.